Astrana Health Overview
Astrana Health Target Price
Analysts' 12-month price predictions for ASTH.
Get informed when a big investor buys or sells
+ FollowShare Price
$43.5
Average Target Price
$43.33
0.4% downside
0.4% downside6 analysts in the last 4 months
High: $50 | Low: $37
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-26 | Barclays | $50 |  14.9% upside |  |
| 2026-05-14 | Truist Financial | $47 | 8% upside | |
| 2026-05-11 | Barclays | $37 | 14.9% downside | |
| 2026-05-08 | NeedhamMatthew Shea | $41 | 5.7% downside | |
| 2026-05-08 | Robert W. Baird | $45 | 3.4% upside | |
| 2026-04-15 | Robert W. Baird | $40 | 8% downside | |
| 2026-02-02 | BTIG | $40 | 8% downside | |
| 2025-12-12 | NeedhamMatthew Shea | $28 | 35.6% downside | |
| 2025-11-25 | Jefferies | $37 | 14.9% downside | |
| 2025-11-24 | BarclaysAndrew Mok | $26 | 40.2% downside | |
| 2025-04-01 | Barclays | $36 | 17.2% downside | |
| 2025-03-03 | Robert W. Baird | $50 | 14.9% upside | |
| 2024-10-03 | BTIGDavid Larsen | $70 | 60.9% upside | |
| 2024-08-15 | Robert W. BairdMichael Ha | $67 | 54% upside | |
| 2024-06-27 | Stifel NicolausChris O'Cull | $48 | 10.3% upside | |